Anand Narayanan Ph.D

• I am a Senior Scientist II in the Biologics Discovery (BD) department at Johnson & Johnson Innovative Medicine (Spring House, PA), where I lead the protein quantification and purity evaluation team within the automated high-throughput protein expression and purification group. My group develops and implements high-throughput analytical workflows that provide accurate concentration measurements, purity assessments, and data pipelines across scalable expression platforms to de-risk and accelerate hit-to-lead progression for biologics programs.
  • While maintaining day-to-day operational excellence, I have directed a multi-disciplinary scientific team and partnered with External Innovations and Legal to evaluate and onboard external assets; developed go/no-go strategy that guided licensing and contract negotiations.
  • I provide scientific leadership for the preclinical progression of mAbs and multispecifics across oncology and immunology programs, driving hit to lead, lead selection, and successful transition to IND enabling activities.
• I was awarded the inaugural Johnson & Johnson Innovative Medicine BD 3-pillar award in the science category for exemplary contributions to BD’s mission of innovation with courage and collaboration with care in 2024.
• Served as podium presenter, panelist and moderator of breakout session at the PEGSBoston 2026

Prior to joining J&J, I served as a research faculty at Yale University and developed end-to-end functional pipelines   Integrating CRISPR/Cas9 gene editing, single cell RNA seq, and NGS to create and phenotype in vitro human disease models.